MIR548AT

Across TCGA pan-cancer cohorts, MIR548AT RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR548AT data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR548AT RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AT expression acts as an unfavorable survival marker, although some lineages such as SARC and LUAD show a favorable association.

KICH, LUSC, and KIRC are the cancer types where MIR548AT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.082	0.877	<.001	78	view →
LUSC	DFS	Tertile	II,III,IV	0.256	0.458	.003	55	view →
KIRC	DFS	Tertile	All	0.535	0.672	.003	45	view →
UVM	OS	Tertile	III,IV	0.104	0.808	.015	27	view →
THYM	OS	Tertile	All	0.817	1.000	<.001	24	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	18	view →
ESCA	OS	Median	II,III,IV	0.326	0.549	.003	14	view →
SARC	DFS	Tertile	All	0.742	0.580	.008	12	view →
LUAD	DFS	Tertile	II,III,IV	0.483	0.194	.013	10	view →
SKCM	OS	Tertile	III,IV	0.729	0.833	.025	9	view →
MESO	OS	Tertile	IV	0.296	0.700	.016	9	view →
LAML	DFS	Median	All	0.461	0.677	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR548AT–KICH (OS)

Open the KICH breakdown →